Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
298 ARTÍCULOS , VIENDO DEL 196 AL 210
Neurotrophic factor therapy for Parkinson's disease
Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH.
Prog Brain Res. 2010;184:237-64. doi: 10.1016/S0079-6123(10)84013-0.
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations
Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG.
Mov Disord. 2010 Dec 15;25(16):2704-16. doi: 10.1002/mds.23190.
Molecular chaperones as rational drug targets for Parkinson's disease therapeutics
Kalia SK, Kalia LV, McLean PJ.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):741-53. doi: 10.2174/187152710793237386.
2-Hydroxy-3-isobutyl-9-[(11)C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine
Leung K.
2006 Mar 17 [updated 2010 Oct 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
The MoCA: well-suited screen for cognitive impairment in Parkinson disease
Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ.
Neurology. 2010 Nov 9;75(19):1717-25. doi: 10.1212/WNL.0b013e3181fc29c9.
Development of Parkinson's disease biomarkers
Prakash KM, Tan EK.
Expert Rev Neurother. 2010 Dec;10(12):1811-25. doi: 10.1586/ern.10.73.
Tic Disorder: An Unusual Presentation of Neurotoxoplasmosis in a Patient with AIDS
Aquino CC, Felício AC, Godeiro-Junior C, Santos-Neto D, Pedroso JL, Oliveira AS, Silva SM, Borges V, Ferraz HB.
Case Rep Neurol. 2010 Nov 15;2(3):145-149. doi: 10.1159/000322185.
α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease
Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M.
Int J Mol Sci. 2010 Oct 29;11(11):4257-66. doi: 10.3390/ijms11114257.
[Transcranial sonography in diagnosis of movement disorders]
Ambrosius W, Kozubski W.
Neurol Neurochir Pol. 2010 Nov-Dec;44(6):574-9. doi: 10.1016/s0028-3843(14)60155-9.
[Orthostatic tremor causing postural instability in Parkinson disease: report of one case]
Aguilar E, Pollak D, Necochea C, Fadic R, Juri C.
Rev Med Chil. 2010 Nov;138(11):1410-3. Epub 2011 Jan 27.
Ross NT, Metkar SR, Le H, Burbank J, Cahill C, Germain A, MacPherson L, Bittker J, Palmer M, Rogers J, Schreiber SL.
2011 Feb 10 [updated 2011 Feb 15]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.
Ross NT, Metkar SR, Le H, Burbank J, Cahill C, Germain A, MacPherson L, Bittker J, Palmer M, Rogers J, Schreiber SL.
2011 Feb 4 [updated 2011 Feb 15]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–.
Involuntary movements during vitamin B12 treatment
Ozdemir O, Baytan B, Gunes AM, Okan M.
J Child Neurol. 2010 Feb;25(2):227-30. doi: 10.1177/0883073809333528. Epub 2009 Jun 12.
[Sleep paroxysmal events in children in video/polysomnography]
Zajac A, Skowronek-Bała B, Wesołowska E, Kaciński M.
Przegl Lek. 2010;67(9):762-9.
Neurological sequelae of hypoxic-ischemic brain injury
Lu-Emerson C, Khot S.
NeuroRehabilitation. 2010;26(1):35-45. doi: 10.3233/NRE-2010-0534.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.